PLoS ONE · 2013 · 29 citations · 21 references
MedicineCell BiologyOncologyMolecular OncologyOncogenesSignal TransductionCancer Cell SignalingMitochondrial SignalingOncogenic Signaling PathwaysRas Family OncogenesMek InhibitorsMek SignalingOncogenic Ras MutationsPi3k-akt-mtor SignalingRaf-mek-erk SignalingRas Signaling PathwaySerine PhosphorylationStat3 Signaling
Activating mutations in the RasGTPases are the most common oncogenic lesions in human cancer. Similarly, elevated STAT3 expression and/or phosphorylation are observed in the majority of human cancers. We recently found that activated Ras requires a mitochondrial rather than a nuclear activity of STAT3 to support cellular transformation. This mitochondrial activity of STAT3 was supported by phosphorylation on serine 727 (S727) in the carboxyl-terminus of STAT3. In this study we show that the H-Ras oncoprotein engages the MEK-ERK pathway to drive phosphorylation of STAT3 on S727, while phosphoinositide 3-kinase (PI3K) and mTOR activity were superfluous. Moreover, pharmacological inhibition of MEK reduced transformation by H-, K-or N-Ras. However, cells expressing a mitochondrially restricted STAT3 with a phospho-mimetic mutation at S727 were partially resistant to inhibition of the ERK pathway, exhibiting a partial rescue of anchorage-independent cell growth in the presence of MEK inhibitor. This study shows that the MEK-ERK pathway is required for activated Ras-induced phosphorylation of STAT3 on S727, that inhibition of STAT3 S727 phosphorylation contributes to the anti-oncogenic potential of MEK inhibitors, and that mitochondrial STAT3 is one of the critical substrates of the Ras-MEK-ERK-axis during cellular transformation.
21
Otto Warbürg · Science · 1956 · 13.3K citations
Function of Mitochondrial Stat3 in Cellular Respiration
Joanna Węgrzyn, Ramesh Potla, Yong-Joon Chwae et al. · Science · 2009 · 1K citations · Full text